Shinji Kihara Selected Research

Adiponectin

10/2008	Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages.
06/2008	Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction.
05/2008	Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
04/2008	Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.
02/2008	Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
01/2008	Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease.
01/2008	Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS) A 42-month prospective study.
09/2007	Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.
06/2007	Adiponectin protects against the development of systolic dysfunction following myocardial infarction.
06/2007	Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment.
04/2007	The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes.
12/2006	Adiponectin and renal function, and implication as a risk of cardiovascular disease.
10/2006	Adiponectin and inflammatory markers in peripheral arterial occlusive disease.
09/2006	Effect of adiponectin on murine colitis induced by dextran sulfate sodium.
06/2006	Adiponectin replenishment ameliorates obesity-related hypertension.
03/2006	Adiponectin: a key adipocytokine in metabolic syndrome.
10/2005	Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.
11/2004	Adiponectin as a biomarker of the metabolic syndrome.
07/2004	Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling.
04/2004	Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.
01/2004	Adiponectin and metabolic syndrome.
12/2003	Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin.
12/2003	Obesity, adiponectin and vascular inflammatory disease.
11/2003	Association of serum adiponectin levels with breast cancer risk.
06/2003	Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
05/2003	Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.
11/2002	Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.
10/2002	Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis.
09/2002	Adiponectin in essential hypertension.
07/2002	Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
07/2002	Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome.
01/2002	Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Articles by Research Topic

Disease

8	Syndrome 04/2008 - 07/2002
5	Obesity 06/2006 - 04/2002
4	Atherosclerosis (Atheroma) 10/2008 - 11/2002
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 04/2002
3	Hypertension (High Blood Pressure) 06/2006 - 09/2002
2	Myocardial Infarction 06/2008 - 06/2007
2	Fibrosis (Cirrhosis) 05/2008 - 09/2007
2	Reperfusion Injury 06/2007 - 10/2005
2	Insulin Resistance 07/2002 - 07/2002
1	Obstructive Sleep Apnea 04/2008
1	Albuminuria 09/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2006
1	Anoxia (Hypoxia) 10/2006
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2006
1	Colitis 09/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2005
1	Ischemia 07/2004
1	Arteriosclerosis 03/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2003
1	Breast Neoplasms (Breast Cancer) 11/2003
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2003
1	Pathologic Constriction (Stenosis) 10/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2002

Drug/Important Bio-Agent (IBA)

32	AdiponectinIBA 10/2008 - 01/2002
1	CholesterolIBA 10/2008
1	Angiotensin IIIBA 05/2008
1	PPAR alphaIBA 05/2008
1	LigandsIBA 02/2008
1	ResistinIBA 01/2008
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2006
1	Dextran SulfateIBA 09/2006
1	Glycerol KinaseIBA 08/2005
1	pioglitazone (Actos)FDA Link 07/2005
1	C-Reactive ProteinIBA 03/2004
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2003
1	AdipokinesIBA 01/2003
1	ApolipoproteinsIBA 11/2002
1	heparin-binding EGF-like growth factor (HB-EGF)IBA 04/2002